These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1943961)

  • 61. Use of IV epinephrine for treatment of patients with contrast reactions: lessons learned from a 5-year experience.
    Collins MS; Hunt CH; Hartman RP
    AJR Am J Roentgenol; 2009 Feb; 192(2):455-61. PubMed ID: 19155410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Side effects of using water-soluble iodine-containing contrast substances].
    Perel'man VM
    Vestn Rentgenol Radiol; 1979; (5):81-4. PubMed ID: 506015
    [No Abstract]   [Full Text] [Related]  

  • 63. Intravenous excretory urography using Optiray in office urology.
    Koncz PM
    Int Urol Nephrol; 1995; 27(3):257-60. PubMed ID: 7591587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Legal implications of the use of radiologic contrast media.
    Friedman PS
    Leg Med Annu; 1975; ():249-60. PubMed ID: 1221237
    [No Abstract]   [Full Text] [Related]  

  • 65. [Comment on the paper: "Death after intravenous administration of Visotrast" in Z.ärztl. Fortbild. 71, (1977),1,p.40-2].
    Barke R
    Z Arztl Fortbild (Jena); 1977 Aug; 71(15):741-3. PubMed ID: 919604
    [No Abstract]   [Full Text] [Related]  

  • 66. Low-versus high-osmolality contrast media for intravenous use: a health care luxury or necessity?
    Powe NR
    Radiology; 1992 Apr; 183(1):21-2. PubMed ID: 1549674
    [No Abstract]   [Full Text] [Related]  

  • 67. Adverse reactions to intravenous contrast media in routine clinical practice.
    Wolf GL; Silvay-Mandeau O
    Invest Radiol; 1990 Sep; 25 Suppl 1():S20-1. PubMed ID: 2283244
    [No Abstract]   [Full Text] [Related]  

  • 68. Electrocardiographic response to intravenous and intraarterial injection of iosimenol (a new, iodinated, non-ionic, iso-osmolar contrast medium).
    Zhang JJ; Morganroth J; Hogstrom B
    J Invasive Cardiol; 2013 Nov; 25(11):573-8. PubMed ID: 24184891
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Studies on a new hepatotropic contrast medium].
    Krueger P
    Med Klin; 1978 Apr; 73(14):516-8. PubMed ID: 634212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Power Injection Through Ultrasound-Guided Intravenous Lines: Safety and Efficacy Under an Institutional Protocol.
    Witting MD; Moayedi S; Dunning K; Babin LS; Cogan BM
    J Emerg Med; 2017 Jan; 52(1):16-22. PubMed ID: 27765438
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Leukergy and intravenous contrast media of Polish origin].
    Milczarek S
    Pol Tyg Lek; 1975 Feb; 30(6):243-5. PubMed ID: 1114120
    [No Abstract]   [Full Text] [Related]  

  • 72. The current status of reactions to intravenous contrast media.
    Ansell G; Tweedie MC; West CR; Evans P; Couch L
    Invest Radiol; 1980; 15(6 Suppl):S32-9. PubMed ID: 7203943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Updated guidelines for intravenous contrast use for CT and MRI.
    Huynh K; Baghdanian AH; Baghdanian AA; Sun DS; Kolli KP; Zagoria RJ
    Emerg Radiol; 2020 Apr; 27(2):115-126. PubMed ID: 31925592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Phlebography using low osmolar contrast media].
    Schmitt HE; Widmer LK
    Vasa; 1984; 13(1):32-5. PubMed ID: 6367257
    [No Abstract]   [Full Text] [Related]  

  • 75. Acute reactions to urographic contrast media.
    Davies P; Roberts MB; Roylance J
    Br Med J; 1975 May; 2(5968):434-7. PubMed ID: 236064
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current use of low-osmolality contrast agents: results of a survey.
    Bettmann MA; Geller SC; McClennan B; Dunnick NR
    AJR Am J Roentgenol; 1989 Nov; 153(5):1079-83. PubMed ID: 2801427
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current usage of nonionic contrast.
    Hopper KD; Lambe H; Matthews YL
    Urol Radiol; 1992; 14(3):218-20. PubMed ID: 1290217
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [CONTRAST MEDIA SIDE-EFFECTS AND HYPERSENSITIVITY MANIFESTATIONS].
    LIESS G; LEYDA H
    Radiol Diagn (Berl); 1963; 51():409-19. PubMed ID: 14122956
    [No Abstract]   [Full Text] [Related]  

  • 79. [Adverse reactions to intravascular contrast media].
    Foradori G; García C; Fava M
    Rev Med Chil; 1991 Jul; 119(7):819-24. PubMed ID: 1844760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Frequency of acute adverse events to a non-ionic low-osmolar contrast medium: the effect of verbal interview.
    Thomsen HS
    Pharmacol Toxicol; 1997 Feb; 80(2):108-10. PubMed ID: 9060043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.